Randomized phase 2 study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

Authors :: Dung T. Le
Todd S. Crocenzi
Jennifer N. Uram
Eric R. Lutz
Daniel A. Laheru
Elizabeth A. Sugar
Robert H. Vonderheide
George A. Fisher
Andrew H. Ko
Aimee Murphy
Katherine McDougall
Sandy Ferber
Dirk G. Brockstedt
Elizabeth M. Jaffee
Source :: Journal of Clinical Oncology. 34:TPS4153-TPS4153
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.

Tools